Every SEC Form 3/4/5 on record for this filer (CIK 1702283) — 4 issuers, 28 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | Director | 2023-10-11 → 2026-06-12 | 6 | $25,800 |
| IONS | IONIS PHARMACEUTICALS INC | Director | 2023-12-18 → 2026-01-20 | 9 | — |
| ACAD | ACADIA PHARMACEUTICALS INC | EVP and CCO · lapsed | 2017-03-31 → 2021-01-08 | 14 | −$7M |
| AKCA | AKCEA THERAPEUTICS, INC. | Director · lapsed | 2019-09-23 → 2020-10-13 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PCRX | 2024-08-14 | Buy | 2,000 | $12.90 | $25,800 | 7,230 |
| ACAD | 2021-01-06 | Sell | 1,120 | $53.34 | $59,741 | 8,059 |
| ACAD | 2020-10-16 | Sell | 1,247 | $42.56 | $53,072 | 6,457 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.
